The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation-Reference-Cited by-同舟云学术

The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation

Published:2014-06 Issue:1 Volume:69 Page:7-21
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Lebrec Hervé,Molinier Brigitte,Boverhof Darrell,Collinge Mark,Freebern Wendy,Henson Kristin,Mytych Daniel T.,Ochs Hans D.,Wange Ronald,Yang Yung,Zhou Lei,Arrington Joshua,Christin-Piché Marie Soleil,Shenton Jacintha

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference90 articles.

1. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris;Abrams;J. Clin. Invest.,1999

2. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement;Aiuti;Nat. Med.,2002

3. Normal immunologic response to a neoantigen, bacteriophage phiX-174, in baboons with long-term lymphohematopoietic reconstitution from highly purified CD34+ Lin- allogeneic marrow cells;Andrews;Blood,1997

4. Comparing exponentially weighted moving average and run rules in process control of semiquantitative immunogenicity immunoassays;Barger;AAPS J.,2010

5. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial;Bingham;Arthritis Rheum.,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: European partnership on the assessment of risks from chemicals (PARC): focus on new approach methodologies (NAMs) in risk assessment;Frontiers in Toxicology;2024-08-08

2. Evaluating the conduct and reporting of the T-cell dependent antibody response in the Extended One-Generation Reproductive Toxicity study provided under the EU REACH regulation;Critical Reviews in Toxicology;2024-07-23

3. Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey;Regulatory Toxicology and Pharmacology;2024-06

4. A modular strategy for the testing and assessment of non-genotoxic carcinogens;Archives of Toxicology;2024-05-29

5. Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys;Current Pharmaceutical Design;2024-05